Title: Clinical study of Nd Yag Laser in the treatment of Posterior Capsular Opacification after Cataract Surgery
Authors: Selvi K, Mishra P, Manavalan S, Sridevi V, Ramya M, Ramakrishnan G
DOI: https://dx.doi.org/10.18535/jmscr/v4i10.115
Abstract
Background: The Nd YAG laser is a solid-state laser with a wavelength of 1064 mm that can disrupt ocular tissues by achieving optical breakdown with a short, high-power pulse. It is a technique for closed-eye, which is being used in the treatment of PCO. Posterior capsular opacification is caused by proliferation of lens epithelial cells which causes fibrotic changes and wrinkling of the posterior capsule and results in decreased vision, glare. Objective: To study the efficacy and complications of Nd YAG laser in treatment of postoperative posterior capsular opacification.
Material and Methods: This study was conducted in the Department of Ophthalmology Rajah Muthiah Medical College Chidambaram, from Oct 2015 to Sep 2016 on 50 patients with significant PCO, using Zeis VISULAS YAG II. These patients were assessed for post-laser visual acuity and possible complications just after 4hrs, 1day, 2 weeks, 3 months, and 6 months.
Result: Out of 50 patients 27 (64 %) were males and 23 (46 %) were females. During and following Nd YAG laser capsulotomy out of 50 patients 4 patients (8%) developed intraocular lens (IOL) pitting, two patients (4%) developed rise in intraocular pressure (IOP), three patients showed iritis (6%), one patient (2%) developed cystoid macular edema (CME). The best corrected visual acuity (VA) of 6/9 – 6/6 was achieved in 36 eyes (72%).
Conclusion: The Nd YAG laser capsulotomy is a safe, effective outpatient procedure to create an opening in opaque posterior capsule for the improvement in vision.
Key words: Nd YAG laser capsulotomy, posterior capsular opacification, visual acuity.
References
11. Murthy GVS, Gupta SK et al. Current status of cataract blindness and vision 2020. Indian J Ophthalmology. 2008;56(6): 489-494
2. Apple DJ, Solomon KD, Tetz MR et al, Posterior capsule opacification. SurvOphthalmol. 1992; 37:73-116.
3. Keates RH, Steinert RF, Puliafitoc A. Long term follow-up of Nd YAG laser posterior capsulotomy. Am Intraocular Implant Soc J.1984; 10; 164-8.
4. Roger F. Steinert, Howard Finek, Howard V. Gimbel et al, “Cataract surgery Technique, Complications and Management”. 2nd Edition. WB Saunders Company. Pg.no.531-544.
5. Peng Q, Henning A, Vasavada AR et al, Posterior capsular plaque a common feature of cataract surgery in the developing world. Am J Ophthalmol 1998; 125:621-26.
6. Schaumberg DA, Dona MR, Christen WG et al, A systematic overview of incidence of posterior capsular opacification. Ophthalmology. 1998; 105: 1213-21.
7. Font RL, Brownstein S. A light and electron microscopic study of anterior subcapsular cataract. Am J ophthalmol. 1974; 78:972-84.
8. McDonell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology. 1983; 90:1548.
9. Cowan A, Fry WE. Secondary cataract with particular reference to transparent globular bodies. Arch ophthalmol. 1937; 18:12-22.
10. Norman S Jaffe, Mark S Jaffe, Gary F. Jaffe. “Cataract surgery and its complications”. 6thEdition. Mosby. Pg.no.404-410.
11. Sir Stewart Duke-elder “System of ophthalmology”. Vol. XI. Disease of lens and vitreous; glaucoma and hypotony. C.V. Mosby Company. Pg. no.233-248.
12. Miyake K, Asabusa M, Kobayash H. Effect of IOL fixation on blood aqueous barrier. Am.J ophthalmology. 1984; 98:451-455.
13. Zaturinsky B, Naveen N, Sakr D et al. Prevention of PCO by cryolysis and” use of heparinised irrigating solution during ECCE in rabbits. Ophthalmol Surg. 1990; 2(6):431-34.
14. Chen RX, Emery JM, Kretzer F. Mitotic inhibitors in preventing PCO. Current concept in cataract surgery: selected proceedings of 7thbiennial cataract surgical congress, New York, 1982, Appleton-century-crofts. Pg. no 217-224.
15. Zaczekl, Zellerstorm C. PCO after phacoemsulifaction in patients with diabetes mellitus. J. Cataract Refract Surgery. 1999; 25:1943-49.
16. Suresh K Pandey, David J Apple, Werner L, Anthony J Maloof, Milverton J.A Review of the Aetiopathogenesis, Experimental and Clinical Studies and Factors for Prevention. Indian J Ophthalmol 2004; 52: 99-112.
17. Sinskey RM, Lain W. The posterior capsule and phacoemulsification. J Am Intraocular Implant Soc. 1978; 4:206.
18. Andrew R Elkington, Helena J Frank Micheal J Greaner. “Clinical optics” 3rdEdition. Blackwell science. Pg.no.216-229.
19. Holladay JT, Bishop JE, Lewis JW. The optimal size of a posterior capsulotomy. Am Intraocular Implant Soc J. 1974; 11:18-20.
20. Aron-Rosa D, Aron JJ, Grisemann M et al, Use of Nd YAG laser to open the PC after lens implant surgery-a preliminary report. J Am Intraocular Implant Soc. 1980; 6:352-4.
21. Prajna NV, Ellwein LB, Selvaraj S, Manjula K, Kupfer C. The Madurai Intraocular Lens Study IV: Posterior Capsule Opacification. Am J Ophthalmol 2000; 130:304–309.
22. Greenidge KC. Nd YAG laser capsulotomy – Energy requirements and visual outcomes. Cataract.
23. Skolnick KA, Perlman JT, Long DM et al. Neodymium:YAG laser posterior capsulotomy performed by residents. J Cataract Refractive Surg.2000;4:597-601.
24. Michael J Flohr, Alan L Robin, James S Kelley. Early complications following Q-switched Nd YAG laser posterior capsulotomy. Ophthalmology. 1985; 9:359-62.
25. Juhas T, Matisova G, Osifova A et al, Neodymium:YAG laser capsulotomy. CeskOftalmol. 1994; 50(1) 45-7.
26. Pop I, Petroi C, Coroi M et al. secondary cataract treatment with laser YAG Nd. Oftalmologia. 2002; 54(3):68-71.